Webinar | If Everyone Has AI, Who Wins SEP Licensing!
3 September | 12:00 PM to 1:00 PM ET: Register Now

Network Bio

Network Bio’s biomedical data for AI-enabled precision medicine
2022
11-50
New York, New York, United States
  • Drug Discovery and Development
  • Healthcare
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

19.5M

Last Funding Amount

17.M

Last Funding Date

27-02-2025

Startup Stage

Seed

Lead Investors

Founders Fund, S32, Artis Ventures, Breyer Capital, Fundomo

People

Founders

About

Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools.

Something missing or incorrect on this page? Help us enrich this information